China's Abogen Biosciences raises $300m in Series C+ round

China's Abogen Biosciences raises $300m in Series C+ round

Vaccine products

30 November, 2021

5Y Capital SoftBank Vision Fund Suzhou Abogen Biosciences

Printed by Unregistered user on Sat, 06 Dec 2025 08:53:38 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's mRNA vaccine technology firm Abogen nabs over $700m

China's Abogen Biosciences raises $92m in Series B round

Read more from Greater China

Alibaba to retire Ele.me brand amid instant-retail push

HongShan aims for $2.9b sale of Golden Goose to Permira by Christmas: report